stockrow
Monday 9 November 2026
Export DHAI’s income statement to Excel — free account
DIH Holding US, Inc.
DHAIDIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.
- Revenue
- −30.7%
- EPS
- +43.1%
- Free cash flow
- −167.9%
Quarter to March 2025, against a year earlier
0.00
0.00
NaN
Follow DHAI
Alert me
DIH Holding US, Inc. (DHAI) P/E ratio
DIH Holding US, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 122× (December 2023) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 23.5× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2025 | 0.0× | — |
| Dec 2024 | 0.0× | — |
| Sep 2024 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| 3 more quarters | Free account |
Against its own ten years
Low 0.0×
High 122×
Ten-year median
0.0×
Current reading's percentile
72
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| ICCM IceCure Medical Ltd. compare | n/m |
| DHAI DIH Holding US, Inc. | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| NXL Nexalin Technology, Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| ADGM Adagio Medical Holdings, Inc. compare | n/m |
| IVF INVO Fertility, Inc compare | n/m |
| GCTK GlucoTrack, Inc. compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)